6657 — Energenesis Biomedical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD4.20bn
- TWD3.51bn
- TWD7.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -150 | -129 | -120 | -266 | -260 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 8.75 | 4.07 | 3.18 | 7.38 | 4.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1.96 | 6.52 | -3.13 | 1.04 | 6.61 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -121 | -98.9 | -97.3 | -233 | -225 |
Capital Expenditures | -1.94 | -2.71 | -8.9 | -6.59 | -0.844 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -242 | 62.2 | -107 | 182 | -58.1 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -244 | 59.4 | -116 | 175 | -59 |
Financing Cash Flow Items | — | — | 0.127 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 437 | 4.77 | 288 | -1.75 | 440 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 71.3 | -34.7 | 74.9 | -59.2 | 156 |